124 related articles for article (PubMed ID: 15095212)
1. Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy.
Teehan GS; Bahdouch D; Ruthazer R; Balakrishnan VS; Snydman DR; Jaber BL
Clin Infect Dis; 2004 Apr; 38(8):1090-4. PubMed ID: 15095212
[TBL] [Abstract][Full Text] [Related]
2. Iron storage indices and risk of bacterial infections in hemodialysis patients.
Teehan GS; Ruthazer R; Balakrishnan VS; Snydman D; Jaber BL
Hemodial Int; 2004 Jul; 8(3):226-32. PubMed ID: 19379422
[TBL] [Abstract][Full Text] [Related]
3. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
4. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients.
Tarng DC; Hung SC; Huang TP
J Am Soc Nephrol; 2004 Sep; 15(9):2486-93. PubMed ID: 15339999
[TBL] [Abstract][Full Text] [Related]
6. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients.
Aslam N; Bernardini J; Fried L; Burr R; Piraino B
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1226-33. PubMed ID: 17699352
[TBL] [Abstract][Full Text] [Related]
7. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis.
Lemaire X; Morena M; Leray-Moragués H; Henriet-Viprey D; Chenine L; Defez-Fougeron C; Canaud B
Blood Purif; 2009; 28(1):21-8. PubMed ID: 19325236
[TBL] [Abstract][Full Text] [Related]
9. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors.
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Nephron Clin Pract; 2007; 107(4):c128-32. PubMed ID: 17957123
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
11. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent associations between iron and mortality in hemodialysis patients.
Kalantar-Zadeh K; Regidor DL; McAllister CJ; Michael B; Warnock DG
J Am Soc Nephrol; 2005 Oct; 16(10):3070-80. PubMed ID: 16033854
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron administration during the maintenance period in erythropoietin-treated hemodialysis patients: a simple and effective method.
Nurnuansuwan S; Leelahavanichkul A; Pansin P; Eiam-Ong S
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S184-8. PubMed ID: 16623026
[TBL] [Abstract][Full Text] [Related]
14. Intravenous iron supplementation in children on hemodialysis.
Leijn E; Monnens LA; Cornelissen EA
J Nephrol; 2004; 17(3):423-6. PubMed ID: 15365964
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
17. Ferritin iron content in haemodialysis patients: comparison with septic and hemochromatosis patients.
Spada PL; Rossi C; Alimonti A; Bocca B; Cozza V; Ricerca BM; Bocci MG; Vulpio C; De Sole P
Clin Biochem; 2008 Aug; 41(12):997-1001. PubMed ID: 18541151
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
19. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
Prakash M; Upadhya S; Prabhu R
Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
[TBL] [Abstract][Full Text] [Related]
20. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
Zacharski LR; Chow BK; Howes PS; Shamayeva G; Baron JA; Dalman RL; Malenka DJ; Ozaki CK; Lavori PW
J Natl Cancer Inst; 2008 Jul; 100(14):996-1002. PubMed ID: 18612130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
